IL43475A - A nonabsorbable,nonnutritive water-soluble flavoring composition and process for preparing the same - Google Patents
A nonabsorbable,nonnutritive water-soluble flavoring composition and process for preparing the sameInfo
- Publication number
- IL43475A IL43475A IL43475A IL4347573A IL43475A IL 43475 A IL43475 A IL 43475A IL 43475 A IL43475 A IL 43475A IL 4347573 A IL4347573 A IL 4347573A IL 43475 A IL43475 A IL 43475A
- Authority
- IL
- Israel
- Prior art keywords
- flavoring
- agent
- composition
- controlling means
- controlling
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims 2
- 239000000796 flavoring agent Substances 0.000 claims 9
- 235000013355 food flavoring agent Nutrition 0.000 claims 9
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 235000003599 food sweetener Nutrition 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 229920000620 organic polymer Polymers 0.000 claims 3
- 239000003765 sweetening agent Substances 0.000 claims 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- 125000000524 functional group Chemical group 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- -1 amino, carboxyl Chemical group 0.000 claims 1
- 150000004982 aromatic amines Chemical class 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 210000004877 mucosa Anatomy 0.000 claims 1
- 230000000050 nutritive effect Effects 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 238000009877 rendering Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
- A23L27/75—Fixation, conservation, or encapsulation of flavouring agents the flavouring agents being bound to a host by chemical, electrical or like forces, e.g. use of precursors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Seasonings (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30085772A | 1972-10-25 | 1972-10-25 | |
| US300499A US3876816A (en) | 1972-10-25 | 1972-10-25 | Nonabsorbable, nonnutritive sweeteners |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL43475A0 IL43475A0 (en) | 1974-01-14 |
| IL43475A true IL43475A (en) | 1976-04-30 |
Family
ID=26971813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL43475A IL43475A (en) | 1972-10-25 | 1973-10-24 | A nonabsorbable,nonnutritive water-soluble flavoring composition and process for preparing the same |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JPS5631944B2 (enExample) |
| CA (1) | CA1011986A (enExample) |
| CH (1) | CH591215A5 (enExample) |
| DE (1) | DE2352905A1 (enExample) |
| FR (1) | FR2204369B1 (enExample) |
| GB (1) | GB1423700A (enExample) |
| IL (1) | IL43475A (enExample) |
| IT (1) | IT1047950B (enExample) |
| NL (1) | NL7314587A (enExample) |
| SU (1) | SU508160A3 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2390111B1 (fr) * | 1977-01-21 | 1988-02-19 | Polak Frutal Works | Procede pour la fixation d'aldehydes aromatisants en vue de leur application dans le domaine alimentaire |
| US4448789A (en) * | 1982-08-27 | 1984-05-15 | Warner-Lambert Company | Enhanced flavor-releasing agent |
| IT1186782B (it) * | 1985-10-18 | 1987-12-16 | Montedison Spa | Processo per la preparazione di fenilpropanoni |
| GB0916178D0 (en) * | 2009-09-15 | 2009-10-28 | Givaudan Sa | Organic compounds |
-
1973
- 1973-10-16 GB GB4814473A patent/GB1423700A/en not_active Expired
- 1973-10-22 DE DE19732352905 patent/DE2352905A1/de not_active Withdrawn
- 1973-10-24 CA CA184,141A patent/CA1011986A/en not_active Expired
- 1973-10-24 IL IL43475A patent/IL43475A/en unknown
- 1973-10-24 NL NL7314587A patent/NL7314587A/xx not_active Application Discontinuation
- 1973-10-24 FR FR7337881A patent/FR2204369B1/fr not_active Expired
- 1973-10-24 SU SU1970654A patent/SU508160A3/ru active
- 1973-10-24 CH CH1500473A patent/CH591215A5/xx not_active IP Right Cessation
- 1973-10-24 IT IT53332/73A patent/IT1047950B/it active
- 1973-10-24 JP JP11906373A patent/JPS5631944B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1423700A (en) | 1976-02-04 |
| IT1047950B (it) | 1980-10-20 |
| JPS49100266A (enExample) | 1974-09-21 |
| IL43475A0 (en) | 1974-01-14 |
| JPS5631944B2 (enExample) | 1981-07-24 |
| CA1011986A (en) | 1977-06-14 |
| DE2352905A1 (de) | 1974-05-09 |
| FR2204369B1 (enExample) | 1979-10-19 |
| NL7314587A (enExample) | 1974-04-29 |
| AU6144173A (en) | 1975-04-17 |
| SU508160A3 (ru) | 1976-03-25 |
| FR2204369A1 (enExample) | 1974-05-24 |
| CH591215A5 (enExample) | 1977-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101918474B (zh) | 羟基聚酰胺胶凝剂 | |
| US5219564A (en) | Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon | |
| Thacharodi et al. | Propranolol hydrochloride release behaviour of crosslinked chitosan membranes | |
| GB929391A (en) | Therapeutic compositions comprising polymeric amines | |
| Rutnakornpituk et al. | Synthesis, characterization and properties of chitosan modified with poly (ethylene glycol)–polydimethylsiloxane amphiphilic block copolymers | |
| EP0008945A3 (en) | Semipermeable composite membrane, process for producing said membrane, and method of desalination using said membrane | |
| JP2011529060A5 (enExample) | ||
| JP2014534467A5 (enExample) | ||
| KR910003606A (ko) | 광중합성 기록물질 | |
| US20110071079A1 (en) | Self-assembling poly(diol citrates)-protein hydrogels | |
| DE50001124D1 (de) | Wasserlösliche oder wasserdispergierbare polymere Salze | |
| CN110882216A (zh) | 一种肿瘤靶向复合纳米酶材料及其制备方法和应用 | |
| IL43475A (en) | A nonabsorbable,nonnutritive water-soluble flavoring composition and process for preparing the same | |
| CN102643420B (zh) | 一种异端基双官能团聚烷基醚类化合物及其用途 | |
| JP2007070277A5 (enExample) | ||
| CN107141492A (zh) | 一种具有靶向功能仿病毒结构高分子囊泡及其制备与应用 | |
| Shen et al. | Antiproliferative activity of polymer-bound, monoamine-coordinated platinum complexes against LNCaP human metastatic prostate adenocarcinoma cells | |
| CN102895195B (zh) | 一种5-氟尿嘧啶分子表面印迹微球制备方法 | |
| GB1428197A (en) | Polyamides | |
| CN108715643B (zh) | 一种环氧与氨基磷酰胆碱聚合物仿生粘附涂层的制备方法 | |
| IE34372L (en) | Solid polyamides | |
| JPS5820647B2 (ja) | 透水性のすぐれた限外「ろ」過膜の製造法 | |
| JPH04215856A (ja) | 陰イオン交換体 | |
| Bonnington et al. | P (CH2OH) 3-polyetheramine-derived polymeric films for enzyme immobilization | |
| Lai et al. | Degradability of the linear azo polymer conjugated 5, 5′‐azodisalicylic acid segment in the main chain for colon‐specific drug delivery |